Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AIM: Direct‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs)....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Clin Pharmacol
Päätekijät: Stolk, Leo M., de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, ten Cate‐Hoek, Arina, Burden, Andrea M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Pharmacoepidemiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495191/
https://ncbi.nlm.nih.gov/pubmed/28326589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13264
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia